On May 8, 2024, JHM Biopharmaceutical (Hangzhou) Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.37 CNY | -0.83% |
|
-5.42% | -22.71% |
21/06 | Dongbao Pharmaceutical Doses First Patient in Diabetes Drug Trial | MT |
15/05 | Tonghua Dongbao Pharmaceutical Launches Phase 1 Trial for Diabetes Injection in China | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.71% | 227.1Cr | |
+2.99% | 9.52TCr | |
-4.34% | 3.75TCr | |
-10.41% | 3.38TCr | |
+75.79% | 2.82TCr | |
-14.61% | 1.56TCr | |
-3.46% | 1.36TCr | |
-12.31% | 1.15TCr | |
+184.77% | 1.08TCr | |
-54.13% | 923.34Cr |
- Stock Market
- Equities
- 600867 Stock
- News Tonghua Dongbao Pharmaceutical Co., Ltd.
- JHM Biopharmaceutical Co., Ltd. announced that it has received CNY 100 million in funding from Tonghua Dongbao Pharmaceutical Co., Ltd.